Soleus Capital Management, L.P. - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of PULMONX CORP
ValueSharesWeighting
Q2 2023$537,510
-32.3%
41,000
-42.3%
0.06%
-26.8%
Q1 2023$793,780
+32.6%
71,0000.0%0.08%
-4.7%
Q4 2022$598,530
-81.0%
71,000
-19.0%
0.09%
-82.5%
Q3 2021$3,152,000
-16.2%
87,612
+2.8%
0.49%
-15.1%
Q2 2021$3,761,00085,2500.58%
Other shareholders
PULMONX CORP shareholders Q4 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 815,019$37,279,00040.66%
Yu Fan 303,030$13,861,00036.18%
ABG Innovation Capital Partners III GP Ltd 833,333$38,117,00018.73%
KPCB XIII Associates, LLC 994,971$45,510,0009.36%
Iron Triangle Partners LP 600,000$27,444,0003.49%
Miura Global Management 405,000$18,525,0003.31%
GREAT POINT PARTNERS LLC 114,345$5,230,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 937,032$42,860,0000.90%
ADAMS STREET PARTNERS LLC 114,661$5,245,0000.84%
RTW INVESTMENTS, LP 1,129,600$51,668,0000.81%
View complete list of PULMONX CORP shareholders